Showing results (31-40 of 74) with videos related to
Sort By:
Pageof 8
Headache|March 4, 2025
Serum levels of autotaxin reveal its role as a novel biomarker of migraineAlberto Ouro, Mónica Castro-Mosquera, Mariña Rodríguez-Arrizabalaga, et al.Journal of Clinical Medicine|July 24, 2021
Characterization of a Temporal Profile of Biomarkers as an Index for Ischemic Stroke Onset DefinitionAndrés Da Silva-Candal, Antonio Dopico-López, Maria Pérez-Mato, et al.Frontiers in Neurology|September 12, 2019
Light-Emitting Diode Photobiomodulation After Cerebral IschemiaBárbara Argibay, Francisco Campos, María Perez-Mato, et al.Translational Stroke Research|June 24, 2021
Neurological Instability in Ischemic Stroke: Relation with Outcome, Latency Time, and Molecular MarkersRamón Iglesias-Rey, Andres da Silva-Candal, Manuel Rodríguez-Yáñez, et al.Journal of Clinical Medicine|June 26, 2025
Is Personalized Mechanical Thrombectomy Based on Clot Characteristics Feasible? A Radiomics Model Using NCECT to Predict FPE in AIS Patients Undergoing ThromboaspirationJacobo Porto-Álvarez, Javier Martínez Fernández, Antonio Jesús Mosqueira Martínez, et al.Scientific Reports|January 17, 2017
Intraarterial route increases the risk of cerebral lesions after mesenchymal cell administration in animal model of ischemiaBárbara Argibay, Jesse Trekker, Uwe Himmelreich, et al.Scientific Reports|May 13, 2021
Random forest-based prediction of stroke outcomeCarlos Fernandez-Lozano, Pablo Hervella, Virginia Mato-Abad, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|July 17, 2019
In vivo ultrasound-activated delivery of recombinant tissue plasminogen activator from the cavity of sub-micrometric capsulesClara Correa-Paz, María F Navarro Poupard, Ester Polo, et al.Journal of Clinical Medicine|February 25, 2022
Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with StrokePaulo Ávila-Gómez, María Pérez-Mato, Pablo Hervella, et al.Annals of Clinical and Translational Neurology|January 21, 2022
sTWEAK is a leukoaraiosis biomarker associated with neurovascular angiopathyAndrés da Silva-Candal, Antia Custodia, Iria López-Dequidt, et al.Pageof 8